Yinghong Zhu
Overview
Explore the profile of Yinghong Zhu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
547
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang B, Shi R, Du W, Guo J, He N, Zhu Y, et al.
Bioorg Chem
. 2025 Mar;
159:108349.
PMID: 40086187
The recurrence of drug-resistant and expensive treatment drugs are major causes of the low survival rate of multiple myeloma (MM) patients. Exploring a safe, effective, low-cost and novel drug treatment...
2.
Chen Z, Zhong M, Lin Y, Zhang W, Zhu Y, Chen L, et al.
J Mol Cell Cardiol
. 2025 Mar;
202:64-80.
PMID: 40068772
Introduction: Lactylation is important for a variety of biological activities. It is reported that Class I histone deacetylases (HDAC1-3) are histone lysine delactylases. However, the role of lactylation in cardiac...
3.
Yang Q, Zhu Y, Jian X, Qiu Y, Zhu Y, Zhao L, et al.
Blood
. 2025 Jan;
PMID: 39786379
Multiple myeloma (MM)-induced bone disease affects not only patients' quality of life but also their overall survival. Our previous work demonstrated that the gut microbiome plays a crucial role in...
4.
He N, Yang Q, Li Z, Guo J, Kuang C, Zhu Y, et al.
Int J Oncol
. 2025 Jan;
66(2.
PMID: 39749708
Multiple myeloma (MM) is a plasma cell malignancy characterized by clonal proliferation in the bone marrow (BM). Previously, it was reported that G‑protein‑coupled receptor 4 (LGR4) contributed to early hematopoiesis...
5.
Li Z, Wu W, Li Q, Heng X, Zhang W, Zhu Y, et al.
Stem Cell Res Ther
. 2024 Jul;
15(1):226.
PMID: 39075623
Background: B-cell CLL/lymphoma 6 member B (BCL6B) operates as a sequence-specific transcriptional repressor within the nucleus, playing crucial roles in various biological functions, including tumor suppression, immune response, stem cell...
6.
He Z, Shen J, Zhu Y, Gao J, Zhang D, Pan X
Water Res
. 2024 May;
258:121802.
PMID: 38796914
Rice paddies are globally important sources of methane emissions and also active regions for methane consumption. However, the impact of fluctuating groundwater levels on methane cycling has received limited attention....
7.
Chen Z, Li L, Chu Y, Zhao F, Zhu Y, Tong S, et al.
Small
. 2024 Jan;
20(26):e2309675.
PMID: 38263847
This study presents a novel approach to enhance the catalytic activity of composite materials by promoting active surface exposure and improving hydrogen transfer performance. Through a self-assembly route involving tailored...
8.
Zhu Y, Jian X, Chen S, An G, Jiang D, Yang Q, et al.
Cell Metab
. 2023 Dec;
36(1):159-175.e8.
PMID: 38113887
The gut microbiome has been found to play a crucial role in the treatment of multiple myeloma (MM), which is still considered incurable due to drug resistance. In previous studies,...
9.
Chen Z, Wang R, Zhu Y, Huang Z, Yang X, Li Q, et al.
Free Radic Biol Med
. 2023 Oct;
209(Pt 2):301-319.
PMID: 37865306
A novel circRNA named circSQSTM1 (hsa_circRNA_075320) was screened out in atorvastatin (ATV) stimulated endothelial cells (ECs) by our group. Considering the anti-atherosclerotic function of ATV, we hypothesized the circSQSTM1 could...
10.
Zhu Y, Yang Q, Yang Q, He Y, Zhou W
Cancers (Basel)
. 2023 May;
15(8).
PMID: 37190210
Hematological malignancies are diverse, with high malignancy characteristics, poor prognoses, and high mortality rates. The development of hematological malignancies is driven by genetic factors, tumor microenvironment factors, or metabolic factors;...